PCSK9 Inhibitors May Increase Parkinson’s Disease & Reduce ALS Risk (2024 Study)

PCSK9 inhibitors significantly reduce the risk of amyotrophic lateral sclerosis (ALS) but increase the risk of Parkinson’s disease (PD). Highlights: ALS Risk Reduction: PCSK9 inhibitors marginally reduced the risk of ALS with an odds ratio of 0.89 (p = 0.048). PD Risk Increase: PCSK9 inhibitors increased the risk of Parkinson’s disease, with an odds ratio …

Read more

Repurposing General Anesthetic Drugs to Treat Depression: Ketamine, Nitrous Oxide, Propofol, Isoflurane (2024 Research)

Repurposing general anesthetic drugs like ketamine for the treatment of major depression represents a significant medical advancement – showcasing rapid and sustained antidepressant effects. Highlights: Rapid Antidepressant Effects: Ketamine, nitrous oxide, propofol, and isoflurane have shown rapid and sustained antidepressant properties, offering new treatment options for major depressive disorder and treatment-resistant depression. Mechanisms of Action: …

Read more

Psychological Trauma & Adversity May Accelerate Biological Aging (2024 Analysis)

Adversity accelerates biological aging through health-compromising behaviors like smoking and possibly social disconnection, and future research needs to focus on causal methodologies to better understand these processes and develop effective interventions. Highlights: Mechanisms of Accelerated Aging: Recent studies suggest that adversity accelerates biological aging, with health-compromising behaviors, especially smoking, playing a significant role in this …

Read more

Sleep Profiles of Different Psychiatric Traits (2024 Study)

Different psychiatric conditions exhibit varied sleep problems, with insomnia and fatigue being the most common issues. Highlights: Worst Sleep Profiles: Traits related to affect disorders, generalized anxiety, and ADHD show the worst sleep problems, including insomnia and fatigue. Milder Sleep Issues: Autism, eating disorders, and impulsivity traits are linked to milder sleep disturbances. Mania and …

Read more

rTMS of Left Dorsolateral Prefrontal Cortex (DL-PFC) May Treat Methamphetamine Addiction via Altering Cravings & Decision Making (2024 Study)

Repetitive transcranial magnetic stimulation (rTMS) on the left dorsolateral prefrontal cortex (dlPFC) improves decision-making and reduces cravings in individuals with methamphetamine use disorder (MUD). Highlights: Improved Decision-Making: rTMS treatment enhanced decision-making abilities in MUD patients, making their choices more rational and similar to healthy individuals. Craving Reduction: Participants experienced a significant decrease in cravings for …

Read more

Type 2 Diabetes Linked to Lower Cerebral Blood Flow (CBF) in Hippocampus (2024 Study)

This study shows that type 2 diabetes causes decreased blood flow and changes in neural activity in specific parts of the hippocampus, which may initially compensate for cognitive decline but deteriorate with worsening diabetes. Highlights: Decreased Perfusion: Patients with type 2 diabetes have lower blood flow in the right hippocampal CA1, DG, and subiculum areas. …

Read more

Deep Brain Stimulation (DBS) of Nucleus Accumbens Treats Cocaine Addiction in Male Rats But Not Females (2024 Study)

Deep brain stimulation (DBS) in the nucleus accumbens reduces cocaine seeking in male rats but is ineffective in female rats, regardless of their estrous cycle phase. Highlights: No FDA-Approved Treatments: There are currently no FDA-approved treatments for cocaine use disorder. DBS Reduces Cocaine Seeking in Males: Previous studies and the current experiment show that DBS …

Read more

Polygenic Scores May Improve Accuracy of ADHD Diagnosis when Combined with Standard Diagnostic Scales (2024 Study)

The ADHD polygenic score (PGS) adds slight yet statistically significant value to existing ADHD diagnostic tools, though it currently lacks clinical utility. Highlights: Study Overview: Researchers tested if adding a genetic score (ADHD PGS) to traditional diagnostic tools (ASRS and WURS scales) and family history could better predict ADHD. Improvement in Diagnosis: Adding the ADHD …

Read more

Micro & Long Non-Coding RNAs in Blood Samples May Accurately Diagnose Depression & Monitor Treatment Responses (2024 Study)

The study suggests that microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in blood and brain tissues can serve as significant biomarkers for diagnosing and monitoring major depressive disorder (MDD). Highlights: Diagnostic Potential: miRNAs and lncRNAs show significant variations in depressed patients, indicating their potential as diagnostic biomarkers for MDD. Treatment Monitoring: Changes in miRNA levels …

Read more

Autism Genetics & Immune Cell Activity: Causal Biomarkers Identified (2024 Study)

A study reported significant causal relationships between specific immune cell subtypes and autism spectrum disorder (ASD), highlighting 26 genetic correlations and potential biomarkers for early detection and treatment. Highlights: Significant Genetic Correlations: The study identifies 26 potential correlations between genetic predispositions in immune cell types (immunophenotypes) and the risk of developing ASD. Bi-Directional Analysis Results: …

Read more